ketamine has been researched along with Chemical and Drug Induced Liver Injury in 19 studies
Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
Chemical and Drug Induced Liver Injury: A spectrum of clinical liver diseases ranging from mild biochemical abnormalities to ACUTE LIVER FAILURE, caused by drugs, drug metabolites, herbal and dietary supplements and chemicals from the environment.
Excerpt | Relevance | Reference |
---|---|---|
"Urological toxicity, hepatotoxicity and cognitive deficits are all reported as adverse effects of the recreational use of ketamine." | 2.48 | Ketamine for chronic noncancer pain: concerns regarding toxicity. ( Bell, RF, 2012) |
"Ketamine is a commonly abused recreational drug in Southeast Asia." | 1.40 | Ketamine-related cholangiopathy: a retrospective study on clinical and imaging findings. ( Ahuja, AT; Chan, AW; Chau, HH; Cho, CC; Hui, JW; Hung, EH; Lung, PF; Yu, WL, 2014) |
" We proposed a systematic classification scheme using FDA-approved drug labeling to assess the DILI potential of drugs, which yielded a benchmark dataset with 287 drugs representing a wide range of therapeutic categories and daily dosage amounts." | 1.37 | FDA-approved drug labeling for the study of drug-induced liver injury. ( Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V, 2011) |
"Ketamine has been shown to prevent these effects." | 1.35 | Ketamine-induced hepatoprotection: the role of heme oxygenase-1. ( Adams, SD; Helmer, KS; Mercer, DW; Suliburk, JW; Ward, JL; Zuckerbraun, BS, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (5.26) | 18.2507 |
2000's | 1 (5.26) | 29.6817 |
2010's | 14 (73.68) | 24.3611 |
2020's | 3 (15.79) | 2.80 |
Authors | Studies |
---|---|
Fourches, D | 1 |
Barnes, JC | 1 |
Day, NC | 1 |
Bradley, P | 1 |
Reed, JZ | 1 |
Tropsha, A | 1 |
Morgan, RE | 2 |
Trauner, M | 1 |
van Staden, CJ | 2 |
Lee, PH | 1 |
Ramachandran, B | 1 |
Eschenberg, M | 1 |
Afshari, CA | 2 |
Qualls, CW | 1 |
Lightfoot-Dunn, R | 1 |
Hamadeh, HK | 2 |
Chen, M | 2 |
Vijay, V | 1 |
Shi, Q | 2 |
Liu, Z | 2 |
Fang, H | 2 |
Tong, W | 3 |
Ding, D | 1 |
Kelly, R | 1 |
Chen, Y | 1 |
Kalyanaraman, N | 1 |
Kalanzi, J | 1 |
Dunn, RT | 1 |
Suzuki, A | 1 |
Thakkar, S | 1 |
Yu, K | 1 |
Hu, C | 1 |
Chen, FH | 1 |
Yu, CF | 1 |
Yang, CL | 1 |
Lin, YC | 1 |
Lin, G | 1 |
Wang, CC | 1 |
Yu, HP | 1 |
Fang, J | 1 |
Chang, NF | 1 |
Hong, JH | 1 |
Zhu, X | 1 |
Kohan, LR | 1 |
Goldstein, RB | 1 |
Xu, W | 1 |
Wang, P | 1 |
Wang, D | 1 |
Liu, K | 1 |
Zhang, S | 1 |
Zhao, W | 1 |
Liu, G | 1 |
Nanagas, K | 1 |
Avera, R | 1 |
Purpura, A | 1 |
Murphy, J | 1 |
Kao, L | 1 |
Wong, GL | 1 |
Tam, YH | 1 |
Ng, CF | 1 |
Chan, AW | 2 |
Choi, PC | 1 |
Chu, WC | 1 |
Lai, PB | 1 |
Chan, HL | 1 |
Wong, VW | 1 |
Yu, WL | 1 |
Cho, CC | 1 |
Lung, PF | 1 |
Hung, EH | 1 |
Hui, JW | 1 |
Chau, HH | 1 |
Ahuja, AT | 1 |
Suliburk, JW | 1 |
Ward, JL | 1 |
Helmer, KS | 1 |
Adams, SD | 1 |
Zuckerbraun, BS | 1 |
Mercer, DW | 1 |
Noppers, IM | 1 |
Niesters, M | 1 |
Aarts, LPHJ | 1 |
Bauer, MCR | 1 |
Drewes, AM | 1 |
Dahan, A | 1 |
Sarton, EY | 1 |
Sear, JW | 1 |
Westerling, D | 1 |
Lindblom, P | 1 |
Bell, RF | 1 |
Kalkan, Y | 1 |
Tomak, Y | 1 |
Altuner, D | 1 |
Tumkaya, L | 1 |
Bostan, H | 1 |
Yilmaz, A | 1 |
Unal, D | 1 |
Kara, A | 1 |
Turan, A | 1 |
Kato, Y | 1 |
Homma, I | 1 |
Ichiyanagi, K | 1 |
2 reviews available for ketamine and Chemical and Drug Induced Liver Injury
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Pr | 2016 |
Ketamine for chronic noncancer pain: concerns regarding toxicity.
Topics: Analgesics; Chemical and Drug Induced Liver Injury; Chronic Pain; Cognition Disorders; Dose-Response | 2012 |
1 trial available for ketamine and Chemical and Drug Induced Liver Injury
Article | Year |
---|---|
Drug-induced liver injury following a repeated course of ketamine treatment for chronic pain in CRPS type 1 patients: a report of 3 cases.
Topics: Adult; Aged; Chemical and Drug Induced Liver Injury; Female; Humans; Ketamine; Male; Middle Aged; Pi | 2011 |
16 other studies available for ketamine and Chemical and Drug Induced Liver Injury
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLI | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Des | 2011 |
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Da | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily | 2013 |
Multimodal imaging reveals transient liver metabolic disturbance and sinusoidal circulation obstruction after a single administration of ketamine/xylazine mixture.
Topics: Animals; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Ketamine; Liver; Magne | 2020 |
Substantial Elevation of Liver Enzymes During Ketamine Infusion: A Case Report.
Topics: Analgesics; Chemical and Drug Induced Liver Injury; Complex Regional Pain Syndromes; Female; Humans; | 2020 |
S-ketamine alleviates carbon tetrachloride-induced hepatic injury and oxidative stress by targeting the Nrf2/HO-1 signaling pathway.
Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Heme Oxygenase (Decyclizing); | 2021 |
Articles You May Have Missed.
Topics: Alcohol Withdrawal Delirium; Antidotes; Carbon Monoxide Poisoning; Chemical and Drug Induced Liver I | 2018 |
Liver injury is common among chronic abusers of ketamine.
Topics: Adult; Bile Ducts; Biopsy; Chemical and Drug Induced Liver Injury; Cholangiopancreatography, Magneti | 2014 |
Ketamine-related cholangiopathy: a retrospective study on clinical and imaging findings.
Topics: Adult; Bile Duct Diseases; Bile Ducts; Chemical and Drug Induced Liver Injury; Cholangiography; Chol | 2014 |
Ketamine-induced hepatoprotection: the role of heme oxygenase-1.
Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbon Monoxide; Chemical an | 2009 |
Ketamine hepato-toxicity in chronic pain management: another example of unexpected toxicity or a predicted result from previous clinical and pre-clinical data?
Topics: Chemical and Drug Induced Liver Injury; Female; Humans; Ketamine; Male; Reflex Sympathetic Dystrophy | 2011 |
Re: Noppers et al., Drug-induced liver injury following a reported course of ketamine treatment for chronic pain in CRPS type I patients. A report on 3 cases. Pain 2011;152:2173-8.
Topics: Chemical and Drug Induced Liver Injury; Female; Humans; Ketamine; Male; Reflex Sympathetic Dystrophy | 2012 |
Hepatic effects of ketamine administration for 2 weeks in rats.
Topics: Analgesics; Anesthetics, Dissociative; Animals; Apoptosis; Calcineurin; Calcineurin Inhibitors; Chem | 2014 |
Postherpetic neuralgia.
Topics: Aged; Aged, 80 and over; Chemical and Drug Induced Liver Injury; Female; Herpesviridae Infections; H | 1995 |